For many Americans, pharmaceutical drugs are too expensive—and thanks to a system of complex and tedious bureaucracy, any effort for meaningful reform has been futile. Cost Plus Drugs wants to change ...

Merck has launched a sweeping cost-cutting effort designed to save $3 billion annually by the end of 2027, the company said Tuesday in its quarterly report. Merck, which is facing plummeting sales of ...

After revealing in February plans to save $2 billion more on top of a previously disclosed cost-cutting initiative, Bristol Myers Squibb is conducting another round of job cuts in the Garden State.

The average cost for a Big Pharma to develop a drug in 2024 was $2.23 billion, up from $2.12 billion the year before. The data come from 20 pharmas that had the highest R&D budgets in 2020, as ...

A powerful group of conservative interest groups and activists penned a letter last week to Republican congressional leaders asking them to rein in a program that provides discounted outpatient drugs ...

Every time Thibault publishes a story, you’ll get an alert straight to your inbox! Enter your email By clicking “Sign up”, you agree to receive emails from ...

Vincerx Pharma (VINC) announced plans to implement cost-controls and explore strategic alternatives to support advancing the Phase 1 study of VIP943, the company’s novel CD123-targeted antibody-drug ...

Aug 4 (Reuters) - Indian drugmaker Aurobindo Pharma (ARBN.NS), opens new tab reported a lower first-quarter profit on Monday, as expenses grew faster than revenue - stung by weak prices in the key U.S ...

The trade deal struck between the European Union and the United States over the weekend could cost the pharmaceutical industry billions, thanks to the 15 percent tariff rate applied to most goods ...